An Open-Label, Randomized Assessment of the Concentrations of Besifloxacin, Moxifloxacin, or Gatifloxacin in the Aqueous Humor of Subjects After a Single Topical Dose.

Trial Profile

An Open-Label, Randomized Assessment of the Concentrations of Besifloxacin, Moxifloxacin, or Gatifloxacin in the Aqueous Humor of Subjects After a Single Topical Dose.

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Feb 2013

At a glance

  • Drugs Besifloxacin; Besifloxacin; Gatifloxacin; Gatifloxacin; Moxifloxacin; Moxifloxacin
  • Indications Bacterial infections; Ophthalmic infections; Postoperative infections
  • Focus Pharmacokinetics
  • Sponsors Bausch & Lomb
  • Most Recent Events

    • 01 Jun 2011 Results published in the Journal of Cataract and Refractive Surgery.
    • 27 Feb 2010 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
    • 27 Feb 2010 Actual initiation date changed from 1 Jan 2009 to 1 Feb 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top